Crunching the Numbers on Stocks that will Benefit as this Market Turns Due North

Crunching the Numbers on Stocks that will Benefit as this Market Turns Due North


If this uncertainty and volatility have you prudently sidelined in cash, know that all things eventually pass, and there are stocks are likely to run as the market reverses and recovers.

A place to start is stocks that are very sensitive to changes in the market’s liquidity, or the ability to sell a sizable number of shares without impacting price.

A Top Wall Street analyst crunched the numbers to stress-test a numerical measure of how much a certain stock has responded to historical changes in the market’s liquidity and shared the results with us.

Below are the Top 10 stocks from his results, as follows:

  1. Vanda Pharmaceuticals (VNDA)
  2. Axcelis Technologies (ACLS)
  3. RadNet (RDNT)
  4. CNO Financial Group (CNO)
  5. Progenics Pharmaceuticals (PGNX)
  6. Perdoceo Education (PRDO)
  7. Cleveland-Cliffs (CLF)
  8. Ultra Clean Holdings (UCTT)
  9. CF Industries Holdings (CF)
  10. Movado Group (MOV)

We are in The Trump Era, ahd President Trump is right in starting the discussion about getting back to work establishing mileposts, benchmarks and criteria for ending the coronavirus shutdowns and returning to work will remove some of the uncertainty present in the economy today.

And with that The Bull will get up and start to run again sooner rather than later I believe.

Here my discussion on the future, “Beyond the Virus: Refocusing on Essential Industries and Businesses” have a look.

Have a healthy day, stay at home!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :